One year of laboratory-based COVID-19 surveillance system in Belgium: main indicators and performance of the laboratories (March 2020-21)
- PMID: 34706768
- PMCID: PMC8548266
- DOI: 10.1186/s13690-021-00704-2
One year of laboratory-based COVID-19 surveillance system in Belgium: main indicators and performance of the laboratories (March 2020-21)
Abstract
Background: With the spread of coronavirus disease 2019 (COVID-19), an existing national laboratory-based surveillance system was adapted to daily monitor the epidemiological situation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in the Belgium by following the number of confirmed SARS-CoV-2 infections, the number of performed tests and the positivity ratio. We present these main indicators of the surveillance over a one-year period as well as the impact of the performance of the laboratories, regarding speed of processing the samples and reporting results, for surveillance.
Methods: We describe the evolution of test capacity, testing strategy and the data collection methods during the first year of the epidemic in Belgium.
Results: Between the 1st of March 2020 and the 28th of February 2021, 9,487,470 tests and 773,078 COVID-19 laboratory confirmed cases were reported. Two epidemic waves occurred, with a peak in April and October 2020. The capacity and performance of the laboratories improved continuously during 2020 resulting in a high level performance. Since the end of November 2020 90 to 95% of the test results are reported at the latest the day after sampling was performed.
Conclusions: Thanks to the effort of all laboratories a performant exhaustive national laboratory-based surveillance system to monitor the epidemiological situation of SARS-CoV-2 was set up in Belgium in 2020. On top of expanding the number of laboratories performing diagnostics and significantly increasing the test capacity in Belgium, turnaround times between sampling and testing as well as reporting were optimized over the first year of this pandemic.
Keywords: Belgium; COVID-19; Laboratory-based surveillance; SARS-CoV-2.
© 2021. The Author(s).
Conflict of interest statement
The authors declare that they have no competing interests.
Figures






Similar articles
-
Nationwide quality assurance of high-throughput diagnostic molecular testing during the SARS-CoV-2 pandemic: role of the Belgian National Reference Centre.Virol J. 2024 Feb 10;21(1):40. doi: 10.1186/s12985-024-02308-y. Virol J. 2024. PMID: 38341597 Free PMC article. Review.
-
Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.Trials. 2021 Jan 8;22(1):39. doi: 10.1186/s13063-020-04982-z. Trials. 2021. PMID: 33419461 Free PMC article.
-
Timeliness and completeness of laboratory-based surveillance of COVID-19 cases in England.Public Health. 2021 May;194:163-166. doi: 10.1016/j.puhe.2021.03.012. Epub 2021 Apr 1. Public Health. 2021. PMID: 33945929 Free PMC article.
-
Surveillance of Coronavirus Disease 2019 (COVID-19) Testing in Clinical Laboratories in Korea.Ann Lab Med. 2021 Mar 1;41(2):225-229. doi: 10.3343/alm.2021.41.2.225. Ann Lab Med. 2021. PMID: 33063685 Free PMC article.
-
Increasing the Efficiency of a National Laboratory Response to COVID-19: a Nationwide Multicenter Evaluation of 47 Commercial SARS-CoV-2 Immunoassays by 41 Laboratories.J Clin Microbiol. 2021 Aug 18;59(9):e0076721. doi: 10.1128/JCM.00767-21. Epub 2021 Aug 18. J Clin Microbiol. 2021. PMID: 34191578 Free PMC article. Review.
Cited by
-
Conceptual causal framework to assess the effect of SARS-CoV-2 variants on COVID-19 disease severity among hospitalized patients.Arch Public Health. 2021 Oct 25;79(1):185. doi: 10.1186/s13690-021-00709-x. Arch Public Health. 2021. PMID: 34696806 Free PMC article.
-
COVID-19 contact tracing in Belgium: main indicators and performance, January - September 2021.Arch Public Health. 2022 Apr 13;80(1):118. doi: 10.1186/s13690-022-00875-6. Arch Public Health. 2022. PMID: 35418097 Free PMC article.
-
Clinical Severity of SARS-CoV-2 Omicron Variant Compared with Delta among Hospitalized COVID-19 Patients in Belgium during Autumn and Winter Season 2021-2022.Viruses. 2022 Jun 14;14(6):1297. doi: 10.3390/v14061297. Viruses. 2022. PMID: 35746768 Free PMC article.
-
Personal characteristics and transmission dynamics associated with SARS-CoV-2 semi-quantitative PCR test results: an observational study from Belgium, 2021-2022.Front Public Health. 2024 Sep 10;12:1429021. doi: 10.3389/fpubh.2024.1429021. eCollection 2024. Front Public Health. 2024. PMID: 39319296 Free PMC article.
-
Nationwide quality assurance of high-throughput diagnostic molecular testing during the SARS-CoV-2 pandemic: role of the Belgian National Reference Centre.Virol J. 2024 Feb 10;21(1):40. doi: 10.1186/s12985-024-02308-y. Virol J. 2024. PMID: 38341597 Free PMC article. Review.
References
-
- World Health Organization . Novel Coronavirus (2019-nCoV) situation report - 1 21 January 2020. 2020.
-
- World Health Organization . Novel Coronavirus (2019-nCoV) situation report - 6 26 January 2020. 2020.
-
- Federal Public Service (FPS) Health, Food Chain Safety and Environment . One repatriated Belgian has tested positive for the novel coronavirus. 2020.
LinkOut - more resources
Full Text Sources
Miscellaneous